Electron cryo-microscopy has revealed the three-dimensional structure of a potassium channel that has a central role in regulating the release of insulin from the pancreas.
The hormone insulin is released from beta cells in the pancreas when the levels of sugar in the blood become too high. High levels of sugar cause the concentration of a molecule called ATP – the energy currency of the cell – to increase inside cells. Ion channels known as KATP channels sense changes in the levels of ATP to allow potassium ions to move out of beta cells, and thus have a central role in regulating blood sugar levels (Ashcroft, 2005). When ATP levels in the cell are high, the KATP channels close, and the resulting changes in the electrical excitability of the beta cell membranes lead to an increase in the release of insulin. Likewise, when blood sugar levels decrease, cellular ATP levels also drop, causing the KATP channels to open so that less insulin is released.
These channels are of considerable medical interest because mutations that affect them can cause diabetes or result in abnormally high levels of insulin, which causes a disease known as hyperinsulinism. Drugs that close KATP channels to stimulate the release of insulin are widely used to treat type II diabetes, while drugs that open these channels are used to treat mild forms of hyperinsulinism. Now, in eLife, James Chen and Show-Ling Shyng and colleagues at the Oregon Health and Science University – including Gregory Martin as first author – report that they have used electron cryo-microscopy (cryo-EM) to determine the structure of a KATP channel in the closed state (Martin et al., 2017). In independent work, Ning Gao, Lei Chen and colleagues at Peking University have used cryo-EM to determine the structure of a closed KATP channel under different conditions (Li et al., 2017).
A pancreatic KATP channel contains four copies of a pore-forming protein called Kir6.2 and four copies of a regulatory protein called SUR1 (Figure 1A). The SUR1 subunits control the flow of potassium ions through the pore formed by the Kir6.2 subunits. ATP closes KATP channels by binding to the Kir6.2 subunits. When blood sugar levels are low, another molecule called ADP along with magnesium ions (together known as MgADP) bind to the SUR1 subunits and the channels open. Other factors also regulate KATP channels, such as the lipid PIP2, which opens the channel (Nichols, 2006).
The structure reported by Martin et al. was of a pancreatic KATP channel prepared in the presence of ATP and glibenclamide (a drug that is known to close the channels), while Li et al. solved the structure of the pancreatic KATP channel prepared in the presence of glibenclamide alone. However, both groups report that the closed channels have similar propeller-shaped structures (Figure 1A).
SUR1 contains a core structure of two membrane-spanning domains and two nucleotide-binding domains (Dean et al., 2001), along with an additional membrane-spanning domain known as TMD0 that is connected to the SUR1 core structure by the L0 linker (Aguilar-Bryan et al., 1995; Figure 1B). The cryo-EM structures show that the SUR1 TMD0 interacts with the Kir6.2 pore. Thus, the cryo-EM structures highlight how TMD0 is important in channel assembly, and explain why this SUR1 domain is a hot spot for mutations that cause hyperinsulinism (Aittoniemi et al., 2009). An unexpected finding is that the SUR1 cores and Kir6.2 do not directly interact, even though the nucleotide-binding domains of SUR1 (which bind to MgADP) are essential for opening the pore (Nichols, 2006) and mutations affecting these domains cause disease (Aittoniemi et al., 2009).
It was known from previous work that Kir6.2 is made of two membrane-spanning helices and two cytoplasmic regions (Figure 1; Hibino et al., 2010). The cryo-EM structures show that ATP, PIP2, and glibenclamide bind to regions of the Kir6.2 and SUR1 subunits, and hence explain why both types of subunits affect the action of these molecules. ATP binds to a site between the cytoplasmic regions of adjacent Kir6.2 subunits and a region of the SUR1 L0 linker. PIP2 binds to an adjacent site that also involves the Kir6.2 cytoplasmic domains and the SUR1 L0 linker, while glibenclamide binds at a site made by a different region of the L0 linker and the core of SUR1.
The structures highlight the dynamics involved in controlling whether the channel is open or closed. Both teams found that there is a subset of closed channels in which the cytoplasmic domains of Kir6.2 are rotated in a way that may represent a transition toward the open state. Notably, Li et al. show that the inner membrane-spanning helices of two of the Kir6.2 subunits are slightly displaced in this subset of channels, which also possess a bound PIP2 molecule.
Previous studies on proteins that structurally resemble SUR1 suggest that, for the channel to open in the presence of MgADP, the SUR1 core has to "untwist" to allow the two nucleotide-binding domains to come into contact (Wilkens, 2015). Further structural studies will be needed to find out whether the twisted SUR1 core in the closed KATP channel is caused by glibenclamide binding to the channel, and to reveal how other drugs that open KATP channels work.
Particular regions in the SUR1 transmembrane domains sense conformational changes in the nucleotide-binding domains caused by MgADP binding. Because these regions also bind to the L0 linker, it is possible that conformational changes in the nucleotide-binding domains may alter the structure of the L0 linker. Structural studies of the channels in the open state would shed more light on whether the L0 linker structure changes and may reveal how mutations in Kir6.2 and SUR1 that disrupt the ability of the channel to close can cause diabetes. The exciting structures of KATP channels reported by Martin et al. and Li et al. lay the foundation for finally answering many of these questions.
SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulatorPhilosophical Transactions of the Royal Society B: Biological Sciences 364:257–267.https://doi.org/10.1098/rstb.2008.0142
ATP-sensitive potassium channelopathies: focus on insulin secretionJournal of Clinical Investigation 115:2047–2058.https://doi.org/10.1172/JCI25495
The human ATP-binding cassette (ABC) transporter superfamilyGenome Research 11:1156–1166.https://doi.org/10.1101/gr.GR-1649R
© 2017, Kanelis
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
Sulfur-aromatic interactions occur in the majority of protein structures, yet little is known about their functional roles in ion channels. Here, we describe a novel molecular motif, the M101 gate latch, which is essential for gating of human Orai1 channels via its sulfur-aromatic interactions with the F99 hydrophobic gate. Molecular dynamics simulations of different Orai variants reveal that the gate latch is mostly engaged in open but not closed channels. In experimental studies, we use metal-ion bridges to show that promoting an M101-F99 bond directly activates Orai1, whereas disrupting this interaction triggers channel closure. Mutational analysis demonstrates that the methionine residue at this position has a unique combination of length, flexibility, and chemistry to act as an effective latch for the phenylalanine gate. Because sulfur-aromatic interactions provide additional stabilization compared to purely hydrophobic interactions, we infer that the six M101-F99 pairs in the hexameric channel provide a substantial energetic contribution to Orai1 activation.
Repression of genes by Polycomb requires that PRC2 modifies their chromatin by trimethylating lysine 27 on histone H3 (H3K27me3). At transcriptionally active genes, di- and trimethylated H3K36 inhibit PRC2. Here, the cryo-EM structure of PRC2 on dinucleosomes reveals how binding of its catalytic subunit EZH2 to nucleosomal DNA orients the H3 N-terminus via an extended network of interactions to place H3K27 into the active site. Unmodified H3K36 occupies a critical position in the EZH2-DNA interface. Mutation of H3K36 to arginine or alanine inhibits H3K27 methylation by PRC2 on nucleosomes in vitro. Accordingly, Drosophila H3K36A and H3K36R mutants show reduced levels of H3K27me3 and defective Polycomb repression of HOX genes. The relay of interactions between EZH2, the nucleosomal DNA and the H3 N-terminus therefore creates the geometry that permits allosteric inhibition of PRC2 by methylated H3K36 in transcriptionally active chromatin.